Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Role Intraoperative Salbutamol Inhaler in Preventing Atelectasis
Sponsor: King Abdullah University Hospital
Summary
Atelectasis is considered a common complication in the perioperative period, especially following surgeries under general anesthesia. Postoperative atelectasis could occur anytime during the perioperative period from intraoperative period to 24 hours postoperative and contribute to a variety of other complications, including hypoxemia and pneumonia. In the literature, several methods were utilized to combat this phenomenon, therefore, we investigate the role of intraoperative salbutamol in reducing the incidence of atelectasis. It is well known that salbutamol could be an adjunctive bronchodilator medication used in the intraoperative anesthetic regimens.
Official title: The Role Intraoperative Salbutamol Inhaler Usage as Part of Intraoperative Regimen in Preventing Atelectasis Following Thoracic, Abdominal and Spinal Surgery in Diabetics Population
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-06
Completion Date
2026-12
Last Updated
2026-05-15
Healthy Volunteers
No
Interventions
Salbutamol (Ventolin®)
-4 puffs of salbutamol (each puff = 100 µg, total dose 200-400 µg)
Locations (1)
King Abdullah University Hospital
Irbid, Jordan